Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2024-09-26 00:00:00 ET · period of report 2024-09-24 · accession 0000950170-24-109733 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-26 | 2024-09-24+ | ROIV | MANCHESTER KEITH S | Dir | S - Sale | $11.67 | -503.0K | 1.28M | -28% | -$5.87M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-09-24 | S | D | 368,052 | $11.63 | 1,412,126 | D | — | — | |
| 2 | Common | Common Shares | 2024-09-25 | S | D | 134,948 | $11.77 | 1,277,178 | D | — | — |